Answers are grounded in this paper and cite their sources.
BACKGROUND: Atopic dermatitis (AtD) is a chronic inflammatory skin disease. Despite the well-established role of cytokines, including interleukin-2 (IL-2), and the JAK-STAT signaling pathway in its pathogenesis, the contribution of IL-2 (-330 T/G, rs2069762) and Janus kinase (JAK) 2 (Val612Phe) gene polymorphisms to disease severity remains poorly understood, particularly in specific populations. Data on the relationship between these genetic variants and the clinical course of atopic dermatitis are lacking, limiting the potential for a personalized approach to risk assessment and disease prognosis. AIM: To investigate the distribution of alleles and genotypes of IL-2 (-330 T/G, rs2069762) and JAK2 (Val612Phe) polymorphisms in patients with AtD and to evaluate their association with disease severity. METHODS: This study included 157 patients with atopic dermatitis and 72 healthy controls. Disease severity was assessed using the Scoring Atopic Dermatitis index (SCORAD). Genotyping of IL-2 (-330 T/G, rs2069762) and JAK2 (Val612Phe) polymorphisms was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis following genomic DNA extraction from peripheral blood. The primary endpoint was the association of these polymorphisms with AtD presence and severity; secondary endpoints included allele and genotype frequencies in the study groups. Statistical analysis comprised comparisons of allele and genotype frequencies, calculation of odds ratios with 95% CI, and assessment of Hardy–Weinberg equilibrium (p 0.05). RESULTS: JAK2 Val612Phe allele frequencies in the overall sample were similar to those in controls (G 97%); no statistically significant associations with AtD or severity were observed (p 0.05). For the IL-2 (-330 T/G) polymorphism, the frequency of the GG homozygotes was higher in patients than in controls (16.6% vs 6.9%, respectively). GG carriage was associated with an increased risk of AtD (OR = 2.66; p = 0.048). In patients with severe disease, the association between GG and disease severity was stronger (OR = 4.0; p = 0.025). No study-related adverse events were recorded. These results should be interpreted in light of study limitations, including the small sample size and the lack of functional data on the effect of the -330G variant on IL-2 expression. CONCLUSION: In this population, the IL-2 -330 T/G polymorphism in the GG homozygous state may be associated with an increased risk and greater severity of AtD, whereas JAK2 Val612Phe showed no significant effect. These findings warrant confirmation in larger, more representative cohorts and, where possible, in functional studies of the -330G variant on IL-2 expression.
No takes yet. Share an insight, caveat, or question.
Kurbanov et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: